Never Miss a Prior Authorization Expiration in Specialty Practices

Imagine this: A patient with a chronic inflammatory condition has been on the same biologic for eight months. The disease is controlled, the infusions are routine, and then one week treatment stops. Nothing changed in the patient’s chart, nothing changed in the treatment plan, and no one on the clinical side made a different call. By the time anyone traced the cause, a gap in care had opened that took weeks to close.

The culprit wasn’t clinical. It was a prior authorization expiration — the point at which an approved authorization reaches the end of its valid coverage window, with the renewal never going out to replace it in time. It surfaces in high-volume clinics far more often than it should and is almost always preventable, once you see how the lapses happen. 

Managing these expirations across a full specialty caseload takes a deliberate process rather than individual memory. At volume, no one can hold dozens of end dates and payer-specific renewal windows in their head, and the moment tracking depends on someone remembering, gaps are sure to follow. 

This post breaks down the two ways expiration management fails in busy specialty practices, what each failure costs, and how to build a renewal workflow that catches every expiration with room to spare. If your clinic has ever restarted a stalled therapy because an authorization lapsed, here is how to make sure it doesn’t happen again.

Why Prior Authorization Expirations Slip Through in Specialty Practices

Prior auth expirations often slip through for a simple reason: Tracking becomes unreliable at volume. The problem rarely comes from carelessness, but from scale colliding with structure. 

A busy specialty practice holds authorizations across many payers at once, each with its own approval window. Expiration dates sit buried in payer portals that no one checks consistently, while renewal lead times shift by payer and by drug class. And in most practices, nothing surfaces an upcoming expiration until someone happens to look. Any one of these is manageable on its own. Together, at scale, they guarantee that some end dates go unwatched.

Payer variation is a root cause of most expiration tracking failures too. For a closer look at bringing order to that complexity, see “Managing 100+ Authorization Rules Across Complex Payers.”

When those schedules do go untracked, the damage takes one of two forms:

1. Billing exposure. An authorization that lapses unnoticed means treatment continues without active coverage. The claim can be denied outright, or paid and later recouped, and depending on the payer contract, the practice may carry compliance risk for services delivered outside an approved window. The practice earned that revenue by delivering care and loses it to an administrative miss.
2. A treatment gap. Here the practice catches the expiration, but it’s too late. The renewal goes in close to the deadline, the new authorization doesn’t clear before the old one lapses, and the patient’s therapy pauses while everyone waits on the payer. For a specialty patient stable on a biologic or an infused therapy, that pause carries real clinical weight, and it arrives at the moment when continuity matters most.

A Simple Way to Track Every Active Authorization Before it Expires

Reliable tracking is what turns those two failures into non-events, and it starts with a single view of every active authorization and when each one needs attention. The renewal countdown table below provides that. Each active authorization gets a row, and the table surfaces the date to begin the renewal rather than only the date coverage ends:

Patient	Drug/Therapy	Payer	Effective Date	Expiration Date	Renewal Initiation Target	Status
Jane D.	Infliximab infusion	Commercial PPO	03/01/2026	09/01/2026	07/15/2026	Active — renewal not started
Marcus T.	Infliximab infusion	Arkansas Medicaid	03/01/2026	09/01/2026	07/01/2026	Active — updated response notes pending

The column that matters most is the renewal initiation target date. Set it by working backward from the payer’s typical turnaround for that drug class, then add a buffer in case the first renewal attempt is denied and has to be resubmitted. For many specialty drugs, that lands 30 to 60 days ahead of expiration. A fast commercial renewal might need only three weeks, while a Medicaid specialty renewal with strict documentation requirements needs more.

Build in the documentation the renewal will require, since it often differs from the initial approval. Arkansas Medicaid, for example, requires prescribers to submit updated notes documenting a positive response to therapy before a renewal is granted. Knowing that ahead of time means the note is ready when the target date arrives instead of becoming one more thing to chase.

Building Renewal Into the Workflow 

A table changes nothing on its own. It earns its keep when someone reviews it on a defined cadence and acts on what it surfaces, which turns expiration management from a reactive scramble into a scheduled responsibility.

Three elements make expiration tracking a genuine process. Someone owns the review by name, so accountability doesn’t dissolve across a busy team. The review happens on a set rhythm, weekly in most high-volume clinics, so nothing ages past its target date unseen. And a clear trigger, the renewal initiation target date, tells that person exactly when to start each renewal.

Timing the check to the right moment matters as much as running it. Industry guidance on prior authorization workflows recommends confirming authorization requirements at scheduling rather than at check-in, so a looming renewal shows up while there is still time to act on it. The broader mechanics of standardizing a PA workflow were covered earlier in this series, so the point here stays narrow. Expiration tracking belongs on the schedule as recurring work with a name attached.

Expiration Management Is Patient Care

Step back, and the stakes of properly tracking PA expirations reach past the revenue cycle. A lapsed authorization interrupts a course of treatment, often for a patient who is stable and doing well, at a point where a pause carries clinical cost. This isn’t a rare occurrence. In a 2025 American Medical Association survey, 88% of physicians reported that prior authorization interferes with continuity of care, and 61% said it can destabilize a patient who was previously stable, meaning the clinical risk isn’t hypothetical. It’s the norm respondents already describe. Seen that way, catching expirations is part of delivering care, and the practices that do it consistently succeed because they have better systems behind the task.

That system is what CareTria Provider Connect provides. It maintains a live tracking layer across every active authorization at once and surfaces upcoming expirations before they arrive, so renewals start on time instead of getting discovered at the pharmacy or the infusion chair.

Frequently Asked Questions About Prior Authorization Expirations

What is a prior authorization expiration?

It’s the end of an approved authorization’s valid coverage window. After that date, the payer no longer guarantees payment for the therapy, and continued treatment requires a renewed authorization.

How far in advance should we start a renewal?

Work backward from the payer’s typical turnaround time for that drug class, and add a buffer in case the first attempt is denied. For many specialty drugs that means starting 30 to 60 days before the expiration date, though fast commercial renewals may need less and strict Medicaid renewals may need more.

What happens if an authorization expires mid-treatment?

Two things can go wrong. If it lapses unnoticed, the practice faces billing exposure, since claims for care delivered without active coverage can be denied or recouped. If it’s caught late, the patient can face a treatment gap while the renewal clears. Both are avoidable with proactive tracking.

Why is expiration tracking harder in high-volume specialty practices?

Volume multiplies the number of authorizations, payers, and renewal windows a team tracks at once, and expiration dates often sit in portals no one checks daily. Without a system that surfaces upcoming expirations automatically, some dates go unwatched.

Does a renewal require the same documentation as the initial authorization?

Not always. Many payers ask for updated clinical notes showing the patient’s response to therapy at renewal, which the initial request wouldn’t have included. Knowing each payer’s renewal requirements in advance keeps the renewal from stalling.